T1	corrected_chemical 193620 193640	miR-27a-3p inhibitor
T2	chemical 193631 193640	inhibitor
T3	disease_or_phenotypic_feature 193659 193675	epilepsy-induced
T4	corrected_disease_or_phenotypic_feature 193659 193697	epilepsy-induced inflammatory response
T5	missed_disease_or_phenotypic_feature 193702 193732	hippocampal neuronal apoptosis
T6	disease_or_phenotypic_feature 193746 193752	MAP2K4
T7	disease_or_phenotypic_feature 193801 193807	common
T8	disease_or_phenotypic_feature 193815 193824	infection
T9	disease_or_phenotypic_feature 193842 193853	candidiasis
T10	chemical 193873 193890	virulence factors
T11	chemical 193996 194007	regorafenib
T12	corrected_disease_or_phenotypic_feature 194029 194062	advanced hepatocellular carcinoma
T13	disease_or_phenotypic_feature 194038 194062	hepatocellular carcinoma
T14	chemical 194069 194078	sorafenib
T15	chemical 194146 194153	glucose
T16	disease_or_phenotypic_feature 194185 194200	type 1 diabetes
T17	chemical 194256 194263	insulin
T18	disease_or_phenotypic_feature 194450 194453	SSc
T19	chemical 194450 194453	SSc
T20	disease_or_phenotypic_feature 194525 194530	blood
T21	chemical 194540 194546	oxygen
T22	chemical 194649 194654	group
T23	disease_or_phenotypic_feature 194660 194664	PTSD
T24	chemical 194665 194670	group
T25	disease_or_phenotypic_feature 194817 194820	AML
T26	chemical 194851 194861	biomarkers
T27	disease_or_phenotypic_feature 194924 194927	get
T28	chemical 195008 195014	enzyme
T29	disease_or_phenotypic_feature 195044 195064	polyarteritis nodosa
T30	chemical 195070 195087	anti-phospholipid
T31	disease_or_phenotypic_feature 195142 195155	Brain Disease
T32	disease_or_phenotypic_feature 195159 195164	MPSII
T33	chemical 195208 195221	Nanoparticles
T34	disease_or_phenotypic_feature 195354 195357	DON
T35	chemical 195405 195415	biomarkers
T36	chemical 195420 195424	drug
T37	disease_or_phenotypic_feature 195490 195496	common
T38	chemical 195497 195506	mycotoxin
T39	corrected_chemical 195568 195589	flupentixol decanoate
T40	chemical 195580 195589	decanoate
T41	disease_or_phenotypic_feature 195610 195623	schizophrenia
T42	chemical 195867 195878	SP-EPN-MYCN
T43	chemical 196038 196047	molecular
T44	disease_or_phenotypic_feature 196055 196065	ependymoma
T45	chemical 196107 196120	tetracyclines
T46	chemical 196177 196196	anhydrotetracycline
T47	disease_or_phenotypic_feature 196343 196347	OTCs
T48	chemical 196375 196386	Tofacitinib
T49	chemical 196396 196410	small-molecule
T50	corrected_chemical 196396 196420	small-molecule inhibitor
T51	chemical 196411 196420	inhibitor
T52	disease_or_phenotypic_feature 196469 196489	rheumatoid arthritis
T53	corrected_chemical 196512 196544	dipeptidyl peptidase-4 inhibitor
T54	chemical 196535 196544	inhibitor
T55	chemical 196545 196556	saxagliptin
T56	missed_chemical 196574 196597	antihyperglycemic agent
T57	disease_or_phenotypic_feature 196615 196630	type 2 diabetes
T58	disease_or_phenotypic_feature 196837 196844	anxiety
T59	disease_or_phenotypic_feature 196845 196854	disease-7
T60	disease_or_phenotypic_feature 196868 196875	Anxiety
T61	chemical 196967 196982	NEO-personality
T62	chemical 196994 197001	NEO-PI)
T63	chemical 197128 197137	molecular
T64	disease_or_phenotypic_feature 197152 197155	CHM
T65	chemical 197295 197302	protein
T66	disease_or_phenotypic_feature 197375 197390	type 2 diabetes
T67	disease_or_phenotypic_feature 197431 197444	liver disease
R1	treats Arg1:T39 Arg2:T41
R2	treats Arg1:T55 Arg2:T57
R3	treats Arg1:T53 Arg2:T57
R4	treats Arg1:T56 Arg2:T57
R5	treats Arg1:T14 Arg2:T13
R6	treats Arg1:T14 Arg2:T12
R7	treats Arg1:T50 Arg2:T52
R8	treats Arg1:T17 Arg2:T16
R9	treats Arg1:T48 Arg2:T52
R10	treats Arg1:T11 Arg2:T12
R11	treats Arg1:T1 Arg2:T5
R12	treats Arg1:T1 Arg2:T4
